We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

4SC's Partner Yakult Honsha Starts Clinical Development with Cancer Compound Resminostat in Japan

News   May 21, 2012

 
4SC's Partner Yakult Honsha Starts Clinical Development with Cancer Compound Resminostat in Japan
 
 
 

RELATED ARTICLES

Treating Blood Cancers With a Low-cost Arthritis Drug

News

A simple arthritis drug could be an effective, low-cost solution to treat patients with blood cancers, according to a new study by the University of Sheffield.

READ MORE

Potential Carcinogen Present in High Levels in E-cigarette Liquids

News

A potential carcinogen called "pulegone" is present in high levels in electronic cigarette liquids and smokeless tobacco products, according to a new study.

READ MORE

Editing the Skeletons of Organic Molecules

News

A new method for editing organic molecules could expand the synthetic possibilities of creating medicines.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE